Oral Finasteride (5 mg and 2 mg) versus Topical Minoxidil 5% in Female Pattern Hair Loss

Background: Female pattern hair loss (FPHL) has a negative psychological and social impact. Lacks of consensus for its treatment as well as inconsistent response to treatment modalities are considered major challenges for physicians. Objectives: To assess the safety and efficacy of oral finasteride...

Full description

Bibliographic Details

Published in:	Clinical Dermatology Review
Main Authors:	Eman Hamed El Morsy, Asmaa Saad Abd Toto, Eman Mohamed Hassan
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-01-01
Subjects:	female pattern hair loss finasteride minoxidil
Online Access:	https://journals.lww.com/10.4103/cdr.cdr_87_24